Friebel Sophie, Thater Andrea, Völkel Vinzenz, Klinkhammer-Schalke Monika, Müller-Nordhorn Jacqueline, Emmert Martin
Gesundheitsökonomie, Qualitätsmanagement und Präferenzforschung in der Onkologie, Universität Bayreuth, Bayreuth, Germany.
Bayerisches Krebsregister, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Bayreuth, Germany.
Gesundheitswesen. 2024 Jul;86(7):515-522. doi: 10.1055/a-2251-5564. Epub 2024 Apr 2.
Breast cancer is the most common cancer and the most common cancer-related cause of death among women in Germany. The treatment in certified breast cancer centre networks is recommended to ensure high-quality care. The aim of the study was to determine the percentage of breast cancer patients receiving cancer treatment in certified breast cancer centre networks in Upper Franconia, Germany.
This study considered the location of treatment and the certification status of providers with regard to initial diagnosis, surgery, chemotherapy, and radiation during breast cancer care. Based on this, we compared patient characteristics receiving cancer care in certified and non-certified cancer centres and their networks. The evaluation was based on a dataset of the Bavarian Cancer Registry (4/2017-3/2022).
The analysis included 5,545 primary tumors from a total of 5,355 patients (age: 64.5±14.2 years; 99.2% female). The percentage of patients receiving care in certified breast cancer centre networks was 78.8% for initial diagnosis, 82.6% for surgery, 79.5% for chemotherapy, and 99.6% for radiation, respectively. The weighted mean across all treatment sequences was 84.3%. Patients receiving care in certified care networks were significantly younger for three therapy sequences (p+<+0.001). In addition, an above-average proportion of patients with advanced tumor stages were treated in non-certified care networks, especially for diagnosis and surgery (p+<+0.001).
Regarding the different treatment sequences, we found differences in the proportion of patients who received quality-assured treatment in certified breast cancer centre networks in Upper Franconia. When comparing similar analysis, the results show an average care percentage of patients receiving care in certified care networks. Furthermore, it should be ensured that patients receive comprehensive information about receiving care in certified cancer centre networks.
乳腺癌是德国女性中最常见的癌症，也是与癌症相关的最常见死因。建议在经认证的乳腺癌中心网络中进行治疗，以确保高质量护理。本研究的目的是确定在德国上弗兰肯地区经认证的乳腺癌中心网络中接受癌症治疗的乳腺癌患者的比例。
本研究考虑了乳腺癌护理期间初始诊断、手术、化疗和放疗的治疗地点及提供者的认证状态。基于此，我们比较了在经认证和未经认证的癌症中心及其网络中接受癌症护理的患者特征。评估基于巴伐利亚癌症登记处的数据集（2017年4月至2022年3月）。
分析包括来自5355名患者的5545个原发性肿瘤（年龄：64.5±14.2岁；99.2%为女性）。在经认证的乳腺癌中心网络中接受护理的患者比例分别为：初始诊断78.8%、手术82.6%、化疗79.5%、放疗99.6%。所有治疗序列的加权平均值为84.3%。在经认证的护理网络中接受护理的患者在三个治疗序列中明显更年轻（p<0.001）。此外，肿瘤分期较晚的患者中，在未经认证的护理网络中接受治疗的比例高于平均水平，尤其是在诊断和手术方面（p<0.001）。
关于不同的治疗序列，我们发现在上弗兰肯地区经认证的乳腺癌中心网络中接受质量保证治疗的患者比例存在差异。在比较类似分析时，结果显示在经认证的护理网络中接受护理的患者的平均护理比例。此外，应确保患者获得有关在经认证的癌症中心网络中接受护理的全面信息。
